Coltene Holding AG (FRA:M3Z)
€ 54.5 (0%) Market Cap: 324.84 Mil Enterprise Value: 353.42 Mil PE Ratio: 20.94 PB Ratio: 3.11 GF Score: 66/100

Full Year 2025 Coltene Holding AG Earnings Call Transcript

Mar 06, 2026 / 09:00AM GMT
Release Date Price: €55.4 (-6.73%)

Key Points

Positve
  • Coltene Holding AG (XSWX:CLTN) maintained net sales at the previous year's level in local currencies despite market uncertainties.
  • The company saw a strong performance in the second half of 2025, with a growth of 4.7% in local currencies and an operating margin of 11%.
  • Coltene launched a new HYDRIM instrument washer in Canada, which received positive customer feedback and contributed to growth.
  • The company has invested in digital marketing and implemented a cloud-based CRM system to enhance sales and customer engagement.
  • Coltene's strategic focus on digital marketing and operational excellence, particularly in North America, is expected to drive future growth.
Negative
  • Operating margin decreased from 10.7% to 8.8%, and free cash flow was significantly below the prior year at CHF8 million.
  • The equity ratio decreased from 58.2% to 54.9%, impacted by foreign currency differences.
  • Net sales decreased by 4.0% in the reporting currency Swiss franc, affected by the weakening of the US and Canadian dollar and the euro.
  • The company faced challenges in the equipment business due to economic uncertainty, particularly in North America.
  • Coltene experienced a destocking of dealers in the area of impression material and wound treatment, impacting sales.
Dominik Arnold
Coltene Holding AG - Chief Executive Officer, Member of the Management Board

Dear analysts, dear investors, welcome to the COLTENE Financial Conference 2025. My name is Dominik Arnold. I'm the CEO of COLTENE. Together with me is Markus Abderhalden, the CFO. Start with the Safe Harbor statement for you to note. We come to the agenda, the highlights. I'm starting with the highlights for 2025, then Markus will go deeper into the financials for 2025. Let me give you an outlook, forward-looking, and then conclude with the Q&A.

Let me start with the key figures and the highlights. Overall, the dental market was flat in 2025, and COLTENE was flat as well. We neither won significant market share nor we lost it. This is not satisfactory because we want to grow faster than the market. That's our aim, that's our goal, and we have achieved that in the second half year.

A mix of flat growth, strong Swiss franc, the tariff-related cost all impacted our EBIT in a negative way. Markus will provide you more details around this in the financial results. How did we execute? COLTENE has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot